Skip to main content
Erschienen in: Supportive Care in Cancer 8/2010

01.08.2010 | Original Article

Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis

verfasst von: Robin J. Bell, Marijana Lijovic, Maria La China, Max Schwarz, Pamela Fradkin, Jo Bradbury, Susan R. Davis

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2010

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to document the psychological well-being of a group of women with invasive breast cancer (BC) on an average of nearly 2 years after their diagnosis.

Methods

Participants were women in the Medical Benefits Fund Australia Limited Foundation Health and Wellbeing after Breast Cancer Study, a cohort study of 1,684 women recruited within 12 months of their diagnosis with invasive BC, who completed their first annual follow-up questionnaire. Psychological well-being was measured using the Psychological General Well Being Index questionnaire (PGWB) in women with BC.

Results

The PGWB questionnaire was completed by 1,589 women on an average of 92 weeks after their BC diagnosis, of whom 46 had evidence of active disease. PGWB total scores for all age groups of the BC cohort were lower than community-based norms (p < 0.001 for age groups ≥70, 60–<70, 50–60; p = 0.002 for age group 40–<50 and p = 0.05 for age group <40). PGWB total scores for the BC cohort were positively associated with age (p < 0.001) and living with others (p < 0.01) and inversely associated with active disease (p < 0.001) and education beyond secondary school (p = 0.03). For the domain of anxiety, there was no statistically significant association with living with others but an inverse association with education beyond school.

Conclusion

A higher level of education may be associated with increased anxiety and lower well-being. Social support is particularly important for women with BC who are known to live alone.
Literatur
1.
Zurück zum Zitat Centers for Disease control and Prevention (CDC) (2004) Cancer survivorship—United States, 1971–2001. Morb Mortal Wkly Rep (MMWR) 53(24):526–529 Centers for Disease control and Prevention (CDC) (2004) Cancer survivorship—United States, 1971–2001. Morb Mortal Wkly Rep (MMWR) 53(24):526–529
2.
Zurück zum Zitat Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104:2608–2613CrossRefPubMed Stanton AL, Ganz PA, Rowland JH, Meyerowitz BE, Krupnick JL, Sears SR (2005) Promoting adjustment after treatment for cancer. Cancer 104:2608–2613CrossRefPubMed
3.
Zurück zum Zitat Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Sem Oncol Nurs 24:208–217CrossRef Ganz PA, Casillas J, Hahn EE (2008) Ensuring quality care for cancer survivors: implementing the survivorship care plan. Sem Oncol Nurs 24:208–217CrossRef
4.
Zurück zum Zitat Andrykowski MA, Lykins E, Floyd A (2008) Psychological health in cancer survivors. Sem Oncol Nurs 24:193–201CrossRef Andrykowski MA, Lykins E, Floyd A (2008) Psychological health in cancer survivors. Sem Oncol Nurs 24:193–201CrossRef
5.
Zurück zum Zitat Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531CrossRefPubMed Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4:523–531CrossRefPubMed
6.
Zurück zum Zitat Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100:1530–1541CrossRefPubMed Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B (2008) Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 100:1530–1541CrossRefPubMed
7.
Zurück zum Zitat Lijovic M, Davis SR, Fradkin P, La China M, Farrugia H, Wolfe R, Bell RJ (2008) Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC cancer 8:126CrossRefPubMed Lijovic M, Davis SR, Fradkin P, La China M, Farrugia H, Wolfe R, Bell RJ (2008) Use of a cancer registry is preferable to a direct-to-community approach for recruitment to a cohort study of wellbeing in women newly diagnosed with invasive breast cancer. BMC cancer 8:126CrossRefPubMed
8.
Zurück zum Zitat Dupuy H (1984) The psychological general well-being (PGWB) index. In: Wenger NMM, Furberg C, Elinson J (eds) Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq Publishing, New York, pp 170–183 Dupuy H (1984) The psychological general well-being (PGWB) index. In: Wenger NMM, Furberg C, Elinson J (eds) Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq Publishing, New York, pp 170–183
9.
Zurück zum Zitat Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847–3853CrossRefPubMed Davison SL, Bell R, Donath S, Montalto JG, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90:3847–3853CrossRefPubMed
10.
Zurück zum Zitat Bell RJ, Donath S, Davison SL, Davis SR (2006) Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women. Menopause (New York, NY) 13:65–71 Bell RJ, Donath S, Davison SL, Davis SR (2006) Endogenous androgen levels and well-being: differences between premenopausal and postmenopausal women. Menopause (New York, NY) 13:65–71
11.
Zurück zum Zitat Australian Bureau of Statistics (1997) SF-36 Population Norms 1995. Canberra, Australia pp 1–38 Australian Bureau of Statistics (1997) SF-36 Population Norms 1995. Canberra, Australia pp 1–38
12.
Zurück zum Zitat Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR (2009) Lack of knowledge of hormone receptor status is associated with lower prevalence of use of endocrine therapy in women with invasive breast cancer. Journal of Women's Health (in press) Bell RJ, Lijovic M, Fradkin P, Bradbury J, La China M, Schwarz M, Wolfe R, Farrugia H, Davis SR (2009) Lack of knowledge of hormone receptor status is associated with lower prevalence of use of endocrine therapy in women with invasive breast cancer. Journal of Women's Health (in press)
13.
Zurück zum Zitat Urquhart DM, Shortreed S, Davis SR, Cicuttini FM, Bell RJ (2009) Are low levels of low back pain intensity and disability associated with reduced well-being in community-based women? Climacteric 12:266–275CrossRefPubMed Urquhart DM, Shortreed S, Davis SR, Cicuttini FM, Bell RJ (2009) Are low levels of low back pain intensity and disability associated with reduced well-being in community-based women? Climacteric 12:266–275CrossRefPubMed
14.
Zurück zum Zitat Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (2005) The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab 90:1542–1549CrossRefPubMed Mukherjee A, Tolhurst-Cleaver S, Ryder WD, Smethurst L, Shalet SM (2005) The characteristics of quality of life impairment in adult growth hormone (GH)-deficient survivors of cancer and their response to GH replacement therapy. J Clin Endocrinol Metab 90:1542–1549CrossRefPubMed
15.
Zurück zum Zitat Baker F, Denniston M, Smith T, West MM (2005) Adult cancer survivors: how are they faring? Cancer 104:2565–2576CrossRefPubMed Baker F, Denniston M, Smith T, West MM (2005) Adult cancer survivors: how are they faring? Cancer 104:2565–2576CrossRefPubMed
16.
Zurück zum Zitat Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21:4184–4193CrossRefPubMed Ganz PA, Greendale GA, Petersen L, Kahn B, Bower JE (2003) Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21:4184–4193CrossRefPubMed
17.
Zurück zum Zitat Zebrack BJ, Yi J, Petersen L, Ganz PA (2008) The impact of cancer and quality of life for long-term survivors. Psycho-oncol 17:891–900CrossRef Zebrack BJ, Yi J, Petersen L, Ganz PA (2008) The impact of cancer and quality of life for long-term survivors. Psycho-oncol 17:891–900CrossRef
18.
Zurück zum Zitat Gudbergsson SB, Fossa SD, Ganz PA, Zebrack BJ, Dahl AA (2007) The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study. Support Care Cancer 15:1309–1318CrossRefPubMed Gudbergsson SB, Fossa SD, Ganz PA, Zebrack BJ, Dahl AA (2007) The associations between living conditions, demography, and the 'impact of cancer' scale in tumor-free cancer survivors: a NOCWO study. Support Care Cancer 15:1309–1318CrossRefPubMed
19.
Zurück zum Zitat Marmot M (2002) The influence of income on health: views of an epidemiologist. Health Aff (Project Hope) 21:31–46CrossRef Marmot M (2002) The influence of income on health: views of an epidemiologist. Health Aff (Project Hope) 21:31–46CrossRef
20.
Zurück zum Zitat Vivar CG, McQueen A (2005) Informational and emotional needs of long-term survivors of breast cancer. J Adv Nurs 51:520–528CrossRefPubMed Vivar CG, McQueen A (2005) Informational and emotional needs of long-term survivors of breast cancer. J Adv Nurs 51:520–528CrossRefPubMed
Metadaten
Titel
Psychological well-being in a cohort of women with invasive breast cancer nearly 2 years after diagnosis
verfasst von
Robin J. Bell
Marijana Lijovic
Maria La China
Max Schwarz
Pamela Fradkin
Jo Bradbury
Susan R. Davis
Publikationsdatum
01.08.2010
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2010
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0726-z

Weitere Artikel der Ausgabe 8/2010

Supportive Care in Cancer 8/2010 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.